January 2025 in “Case Reports in Dermatological Medicine”
This report describes an eight-year-old girl with severe hairshaftabnormalities who showed significant improvement after a single session of adipose tissue–derived exosome therapy, highlighting its potential as an innovative treatment option and the need for further studies to confirm its efficacy and safety.
This article reviews the clinical and diagnostic features of hairshaft disorders, emphasizing the role of structured patient assessments and the avoidance of hair trauma, but reports no new results.
23 citations
,
February 2015 in “The American journal of pathology”
This study found that the absence of sebaceous glands may be an early factor in the development of keratosis pilaris, leading to hairshaft and skin barrier abnormalities, independent of filaggrin mutations.
61 citations
,
April 1980 in “Journal of the American Academy of Dermatology”
This case study describes a young woman with a unique syndrome combining lamellar ichthyosis, neuroectodermal and mesodermal defects, and hair with trichoschisis and low sulfur content.
Hair loss may be linked to the GPR133 receptor, independent of the androgen receptor pathway. Treatments like finasteride, dutasteride, minoxidil, RU58841, and KX-826 show varying results, with hair loss persisting due to high testosterone and GPR133's role.
Hair loss is influenced by genetics and sensitivity to hormones like DHT. Treatments like Minoxidil and finasteride are commonly used, and baldness persists as it doesn't affect reproductive success.
Promising hair loss treatments in 2026 include GT20029, a topical androgen receptor degrader, and VDPHL01, an extended-release oral minoxidil, both offering safer alternatives with fewer side effects. Other treatments like sublingual minoxidil, OND-1, JW0061, TDM-105795, and AMP-303 are also being explored.
A bodybuilder's hair transplant appears unnatural with a straight hairline and low density, possibly worsened by not using finasteride. The Turkish clinic is criticized for poor design, and the transplant may have been free for promotion.
A user experienced positive hair regrowth after 9 months using Dutasteride (0.5mg daily) and oral Minoxidil (2.5mg daily) without side effects and plans a hair transplant. They noted the cost-effectiveness of oral Minoxidil and discussed hair loss treatments, including Finasteride.
How does cetirizine reduce inflammation linked to hair loss?Cetirizine is proposed to lower prostaglandin D2 and raise prostaglandin E2 around hair follicles; three small trials of a compounded 1% topical report modest increases in hair density and shaft thickness, with minoxidil doing better head-to-head. Topical cetirizine is off-label and unapproved for hair loss, and the evidence is too thin to call it effective or safe.